Multimodal imaging, including computed tomography angiography and computed tomography perfusion imaging, yields additional information on intracranial vessels and brain perfusion and can differentiate between ischemic core and penumbra which may affect patient selection for intravenous thrombolysis.
Hypothesis
The use of multimodal imaging will increase the number of patients receiving intravenous thrombolysis and lead to better treatment outcomes.
Sample size
400 patients.
Methods and design
PRACTISE is a prospective, multicenter, randomized, controlled trial in which patients presenting within 4.5 h of symptom onset are randomized to either the current evidence-based imaging (NCCT alone) or additional multimodal computed tomography imaging (NCCT + computed tomography angiography + computed tomography perfusion). Clinical decisions on intravenous recombinant tissue plasminogen activator are documented. Total imaging time in both arms and time to initiation of treatment delivery in those treated with intravenous recombinant tissue plasminogen activator, is recorded. Follow-up will include brain imaging at 24 h to document infarct size, the presence of edema and the presence of intra-cerebral hemorrhage. Clinical evaluations include NIHSS score at baseline, 24 h and day 7 ± 2, and mRS at day 90 to define functional outcomes.
Study outcomes
The primary outcome is the proportion of patients receiving intravenous recombinant tissue plasminogen activator. Secondary end-points evaluate times to decision-making, comparison of different image processing software and clinical outcomes at three months.
Discussion
Multimodal computed tomography is a widely available tool for patient selection for revascularization therapy, but it is currently unknown whether the use of additional imaging in all stroke patients is beneficial. The study opened for recruitment in March 2015 and will provide data on the value of multimodal imaging in treatment decisions for acute stroke.
TurnerMBarberMDoddsHDennisMLanghornePMacleodM-J. Stroke patients admitted within normal working hours are more likely to achieve process standards and to have better outcomes. J Neurol Neurosurg Psychiatry2016; 87: 138–142.
2.
KatzanILHammerMDHixsonEDFurlanAJAbou-CheblANadzamDM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol2004; 61: 346–350.
3.
HakimAM. The future of stroke thrombolysis. Ann N Y Acad Sci2012; 1268: 8–13.
4.
CochoDBelvisRMarti-FabregasJ. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology2005; 64: 719–720.
5.
AsaithambiGTongXGeorgeMG. Acute stroke reperfusion therapy trends in the expanded treatment window era. J Stroke Cerebrovas Dis2014; 23: 2316–2321.
6.
TongD. Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine. Neurology2011; 76: 1780–1781.
7.
KvistadCELogalloNThomassenLWaje-AndreassenUBroggerJNaessH. Safety of off-label stroke treatment with tissue plasminogen activator. Acta Neurol Scand2013; 128: 48–53.
8.
BreuerLBlinzlerCHuttnerHBKiphuthICSchwabSKohrmannM. Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of ‘minor stroke'. Cerebrovasc Dis2011; 32: 177–185.
9.
ChalelaJAKidwellCSNentwichLM. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet2007; 369: 293–298.
10.
KaneIWhiteleyWNSandercockPAWardlawJM. Availability of CT and MR for assessing patients with acute stroke. Cerebrovasc Dis2008; 25: 375–377.
11.
SingerOCSitzerMdu Mesnil de RochemontRNeumann-HaefelinT. Practical limitations of acute stroke MRI due to patient-related problems. Neurology2004; 62: 1848–1849.
12.
LiebeskindDSAlexandrovAV. Advanced multimodal CT/MRI approaches to hyperacute stroke diagnosis, treatment, and monitoring. Ann N Y Acad Sci2012; 1268: 1–7.
13.
BivardALeviCKrishnamurthyV. Perfusion computed tomography to assist decision making for stroke thrombolysis. Brain2015; 138(Pt 7): 1919–1931.
14.
ObachVOleagaLUrraX. Multimodal CT-assisted thrombolysis in patients with acute stroke: a cohort study. Stroke2011; 42: 1129–1131.
15.
CampbellBCWeirLDesmondPM. CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke. J Neurol Neurosurg Psychiatry2013; 84: 613–618.
16.
BurtonKRDhanoaDAvivRI. Perfusion CT for selecting patients with acute ischemic stroke for intravenous thrombolytic therapy. Radiology2015; 274: 103–114.
17.
GoyalMMenonBKvan ZwamWH. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet2016; 387: 1723–1731.
18.
MenonBKCampbellBCLeviCGoyalM. Role of imaging in current acute ischemic stroke workflow for endovascular therapy. Stroke2015; 46: 1453–1461.
19.
BrottTAdamsHPJrOlingerCP. Measurements of acute cerebral infarction: a clinical examination scale. Stroke1989; 20: 864–870.
20.
van SwietenJCKoudstaalPJVisserMCSchoutenHJvan GijnJ. Interobserver agreement for the assessment of handicap in stroke patients. Stroke1988; 19: 604–607.
21.
SaverJLFilipBHamiltonS. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke2010; 41: 992–995.
22.
McVerryFDaniKAMacDougallNJMacLeodMJWardlawJMuirKW. Derivation and evaluation of thresholds for core and tissue at risk of infarction using CT perfusion. J Neuroimaging2014; 24: 562–568.
23.
BivardASprattNLeviCParsonsM. Perfusion computer tomography: imaging and clinical validation in acute ischaemic stroke. Brain2011; 134(Pt 11): 3408–3416.
24.
BarberPAZhangJDemchukAMHillMDBuchanAM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology2001; 56: 1015–1020.
25.
McDonaldJSFanJKallmesDFCloftHJ. Pretreatment advanced imaging in patients with stroke treated with IV thrombolysis: evaluation of a multihospital data base. AJNR2014; 35: 478–481.
26.
HackeWFurlanAJAl-RawiY. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol2009; 8: 141–150.
27.
DavisSMDonnanGAParsonsMW. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol2008; 7: 299–309.
28.
Alawneh J and Baron JC. Penumbral imaging in acute stroke: a triumph of hope over experience? ACNR 2014; 14: 18–23.
29.
von KummerRDzialowskiIGerberJ. Therapeutic efficacy of brain imaging in acute ischemic stroke patients. J Neuroradiol2015; 42: 47–54.
30.
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovas Dis 2008; 25: 457–507.
31.
von KummerRBourquainHBastianelloS. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology2001; 219: 95–100.
32.
ChalelaJAKidwellCSNentwichLM. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet2007; 369: 293–298.
33.
MuirKWBaird-GunningJWalkerLBairdTMcCormickMCouttsSB. Can the ischemic penumbra be identified on noncontrast CT of acute stroke?Stroke2007; 38: 2485–2490.
34.
WardlawJMFarrallAJPerryD. Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke2007; 38: 1250–1256.
35.
DzialowskiIHillMDCouttsSB. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke2006; 37: 973–978.
KentDMHillMDRuthazerR. “Clinical-CT mismatch” and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke2005; 36: 1695–1699.
38.
IST-3 collaborative group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol 2015; 14: 485–496.
39.
MairGBoydEVChappellFM. Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic stroke. Stroke2015; 46: 102–107.
40.
NovotnaJKadlecovaPCzlonkowskaA. Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtype. J Stroke Cerebrovasc Dis2014; 23: 2533–2539.
41.
SabarudinASubramaniamCSunZ. Cerebral CT angiography and CT perfusion in acute stroke detection: a systematic review of diagnostic value. Quant Imaging Med Surg2014; 4: 282–290.
42.
SaqqurMUchinoKDemchukAM. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke2007; 38: 948–954.
43.
SimsJRRordorfGSmithEE. Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. AJNR2005; 26: 246–251.
44.
DaniKAThomasRGChappellFMShulerKMuirKWWardlawJM. Systematic review of perfusion imaging with computed tomography and magnetic resonance in acute ischemic stroke: heterogeneity of acquisition and postprocessing parameters: a translational medicine research collaboration multicentre acute stroke imaging study. Stroke2012; 43: 563–566.
45.
CampbellBCMitchellPJKleinigTJ. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med2015; 372: 1009–1018.
46.
GoyalMDemchukAMMenonBK. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med2015; 372: 1019–1030.
47.
JovinTGChamorroACoboE. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med2015; 372: 2296–2306.
48.
SaverJLGoyalMBonafeA. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med2015; 372: 2285–2295.
49.
Barlinn K, Seibt J, Engellandt K, Gerber J, et al. Multimodal computed tomography based definition of cerebral imaging profiles for acute stroke reperfusion therapy (CT-DEFINE): results of a prospective observational study. Clinical Neuroradiol 2015; 25: 403–410.
50.
DaniKAThomasRGChappellFM. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol2011; 70: 384–401.
51.
GentileNTCernetichJKanamallaUS. Expedited computed tomography perfusion and angiography in acute ischemic stroke: a feasibility study. J Emerg Med2012; 43: 308–315.
52.
SalottoloKMFanaleCVLeonardKAFreiDFBar-OrD. Multimodal imaging does not delay intravenous thrombolytic therapy in acute stroke. AJNR2011; 32: 864–868.
53.
SztrihaLKManawaduDJaroszJKeepJKalraL. Safety and clinical outcome of thrombolysis in ischaemic stroke using a perfusion CT mismatch between 3 and 6 hours. PloS One2011; 6: e25796.
54.
BalSMenonBKDemchukAMHillMD. Routine CT angiography in acute stroke does not delay thrombolytic therapy. Can J Neurol Sci2012; 39: 499–501.
55.
Garcia PastorADiaz OteroFGil NavarroS. Vascular imaging before intravenous thrombolysis: consequences of in-hospital delay in applying two diagnostic procedures. J Neuroimaging2015; 25: 397–402.
56.
EichelRCohenJEGomoriJMBen-HurTKeiglerGLekerRR. Is vascular imaging valuable prior to administration of intravenous tissue plasminogen activator?J Clin Neurosci2014; 21: 1691–1694.
57.
ShamyMCJaigobinCS. The complexities of acute stroke decision-making: a survey of neurologists. Neurology2013; 81: 1130–1133.
58.
SharmaMPelzDM. CT perfusion in acute stroke: added value or waste of time?Stroke2013; 44: e115.
59.
BorstJBerkhemerOARoosYB. Value of computed tomographic perfusion-based patient selection for intra-arterial acute ischemic stroke treatment. Stroke2015; 46: 3375–3382.
LevineSRKhatriPBroderickJP. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke2013; 44: 2500–2505.
62.
DirksMNiessenLWKoudstaalPJFrankeCLvan OostenbruggeRJDippelDW. Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. J Neurol Neurosurg Psychiatry2007; 78: 685–689.
63.
LaurencinCPhilippeauFBlanc-LasserreK. Thrombolysis for acute minor stroke: outcome and barriers to management. Results from the RESUVAL Stroke Network. Cerebrovasc Dis2015; 40: 3–9.
64.
SatoSUeharaTOharaTSuzukiRToyodaKMinematsuK. Factors associated with unfavorable outcome in minor ischemic stroke. Neurology2014; 83: 174–181.
65.
CouttsSBO'ReillyCHillMD. Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack. Int J Stroke2009; 4: 448–453.
66.
van den WijngaardIRAlgraALycklamaANGJBoitenJWermerMJvan WalderveenMA. Value of whole brain computed tomography perfusion for predicting outcome after TIA or minor ischemic stroke. J Stroke Cerebrovasc Dis2015; 24: 2081–2087.
67.
EdgellRCVoraNA. Neuroimaging markers of hemorrhagic risk with stroke reperfusion therapy. Neurology2012; 79(13 Suppl 1): S100–S104.
68.
TarpleyJFrancDTansyAPLiebeskindDS. Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions. Curr Atheroscler Rep2013; 15: 336.
69.
WardlawJMMuirKWMacleodMJ. Clinical relevance and practical implications of trials of perfusion and angiographic imaging in patients with acute ischaemic stroke: a multicentre cohort imaging study. J Neurol Neurosurg Psychiatry2013; 84: 1001–1007.
70.
BivardALouMLeviCR. Too good to treat? Ischemic stroke patients with small computed tomography perfusion lesions may not benefit from thrombolysis. Ann Neurol2016; 80: 286–293.
71.
GoyalNMaleSAl WafaiABellamkondaSZandR. Cost burden of stroke mimics and transient ischemic attack after intravenous tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis2015; 24: 828–833.
72.
NguyenPLChangJJ. Stroke mimics and acute stroke evaluation: clinical differentiation and complications after intravenous tissue plasminogen activator. J Emerg Med2015; 49: 244–252.
73.
TsivgoulisGZandRKatsanosAH. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis. Stroke2015; 46: 1281–1287.
NieuwkampDJvan der SchaafICBiesselsGJ. Migraine aura presenting as dysphasia with global cognitive dysfunction and abnormalities on perfusion CT. Cephalalgia2010; 30: 1007–1009.
76.
ShahLRanaSValerianoJScottTF. Reversible CT perfusion abnormalities in patient with migraine variant: a two phase process. Clin Neurol Neurosurg2013; 115: 830–832.
77.
YoungKCBeneschCGJahromiBS. Cost-effectiveness of multimodal CT for evaluating acute stroke. Neurology2010; 75: 1678–1685.
78.
JacksonDEarnshawSRFarkouhRSchwammL. Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspective. AJNR2010; 31: 1669–1674.
79.
EarnshawSRMcDadeCChapmanAMJacksonDSchwammL. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom. Clin Therap2012; 34: 1544–1558.
80.
EmbersonJLeesKRLydenP. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet2014; 384: 1929–1935.
